| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GILD | Common Stock | Options Exercise | +3,025 | +2.3% | 132,781 | 10 Mar 2024 | Direct | F1, F2 | ||
| transaction | GILD | Common Stock | Options Exercise | +6,707 | +5.1% | 139,488 | 10 Mar 2024 | Direct | F1 | ||
| transaction | GILD | Common Stock | Tax liability | $338,416 | -4,505 | -3.2% | $75.12 | 134,983 | 10 Mar 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GILD | Restricted Stock Unit | Options Exercise | -3,025 | -7.9% | 35,040 | 10 Mar 2024 | Common Stock | 3,025 | Direct | F1, F3 | |||
| transaction | GILD | Restricted Stock Unit | Options Exercise | -6,707 | -19% | 28,333 | 10 Mar 2024 | Common Stock | 6,707 | Direct | F1, F4 | |||
| transaction | GILD | Non-qualified Stock Option (Right to Buy) | Award | $0 | +87,970 | $0.000000 | 87,970 | 10 Mar 2024 | Common Stock | 87,970 | $75.12 | Direct | F5 | |
| transaction | GILD | Restricted Stock Unit | Award | +17,305 | +59% | 46,407 | 10 Mar 2024 | Common Stock | 17,305 | Direct | F1, F4 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| F2 | Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan. |
| F3 | The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested. |
| F4 | The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| F5 | The options have a four year vesting schedule. 25% vest on the first anniversary date of the date grant. The balance will vest 6.25% quarterly thereafter until fully vested. |